Beyond Buffett, Beta & Billions: INR 10 Billion equity specialist OmniScience Capital unveils portfolio management services
OmniScience Capital today announced its entry in the fast growing PMS (Portfolio Management Services) industry (~5X in 5 years: APMI) and aims to raise assets under management (AUM) of INR 250 crores in the first year, and INR 1000 crores in three years. OmniScience Capital demonstrating skin in the game has gone live with 22 strategies seeded with proprietary capital.
OmniScience prides itself on its vision to practice investment management as a profession focused on performance, rather than an asset gathering business. The firm’s first principles based Scientific Investing Framework, applied to assets of INR 10 billion across multiple market cycles has proven itself through client delight as demonstrated by their continued commitments.
“When performance leads, the ecosystem wins.” said Dr. Vikas V Gupta, CEO and Chief Investment Strategist at OmniScience Capital. “Over nearly a decade the OmniScience team has developed a niche Scientific Investing Ecosystem of Scientific Investors, Scientific Partners and the Scientific Manager.”
Scientific Investing approach of Chasing Safety to Hunt for True Alpha goes beyond the typical style-based approach, in the PMS/AIF/MF industry, of growth, quality, value, momentum or size, each of which can be replicated with smart beta and masquerades as alpha in its own favourable cycle. Scientific Investing approach inspired by but going beyond Graham, Buffett, and Lynch is designed to bring robustness across different market cycles With the launch of OmniScience’s PMS, the so far elusive OmniScience offerings will remain exclusive, targeted to a wider sophisticated group of Scientific Investors—those who value originality, character, and patience.
Three Product Categories: Omni Crest, Omni Inevitables, and Omni Institutional
As part of its PMS launch, OmniScience introduces three distinct product categories designed to anchor both Foundational and Inevitable allocations within client portfolios:
• Omni Crest – Foundational strategies leveraging OmniScience’s alpha-generation expertise.
• Omni Inevitables – Scientific exposure to India’s uncorrelated structural growth vectors.
• Omni Institutional – Scientifically designed custom solutions for institutional investors.
Among these, Omni Inevitables represents a key innovation.
“In a fast-growing economy like India—amid a transformative global landscape—there are numerous Inevitables. These are businesses and sectors that are likely to thrive. Investing in them enables investors to participate in India’s evolution while generating alpha through uncorrelated opportunities.” said Ashwini Shami, President and Chief Portfolio Manager, OmniScience Capital.
Above views are of the author and not of the website kindly read disclaimer
Tag News
Quote on AMFI Data by Dr. Vikas Gupta, CEO & Chief Investment Strategist at OmniScience Capital
